Atlas Trials

European Organisation for Research and Treatment of Cancer - EORTC

352 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch European Organisation for Research and Treatment of Cancer - EORTC

RecordFirmDate
Adjuvant PEG Intron in Ulcerated Melanoma (NCT01502696)European Organisation for Research and Treatment of Cancer - EORTC2012-10-01
CREATE: Cross-tumoral Phase 2 With Crizotinib (NCT01524926)European Organisation for Research and Treatment of Cancer - EORTC2012-09-01
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer (NCT01402271)European Organisation for Research and Treatment of Cancer - EORTC2012-07-01
Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck (NCT01538381)European Organisation for Research and Treatment of Cancer - EORTC2012-07-01
Empirical Versus Preemptive Antifungal Therapy (NCT01288378)European Organisation for Research and Treatment of Cancer - EORTC2012-03-01
Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma (NCT01344018)European Organisation for Research and Treatment of Cancer - EORTC2012-01-01
Bevacizumab and Lomustine for Recurrent GBM (NCT01290939)European Organisation for Research and Treatment of Cancer - EORTC2011-10-01
Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy (NCT01208064)European Organisation for Research and Treatment of Cancer - EORTC2011-07-01
Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998 (NCT01298388)European Organisation for Research and Treatment of Cancer - EORTC2011-07-01
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01185886)European Organisation for Research and Treatment of Cancer - EORTC2011-06-01
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma (NCT01189253)European Organisation for Research and Treatment of Cancer - EORTC2011-05-01
Bevacizumab in Recurrent Grade II and III Glioma (NCT01164189)European Organisation for Research and Treatment of Cancer - EORTC2011-02-01
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer (NCT01123473)European Organisation for Research and Treatment of Cancer - EORTC2010-12-01
Male Breast Cancer: Understanding the Biology for Improved Patient Care (NCT01101425)European Organisation for Research and Treatment of Cancer - EORTC2010-12-01
Lenalidomide Maintenance Post-debulking in Advanced CTCL (NCT01098656)European Organisation for Research and Treatment of Cancer - EORTC2010-07-01
Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (NCT01099423)European Organisation for Research and Treatment of Cancer - EORTC2010-04-01
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma (NCT01019434)European Organisation for Research and Treatment of Cancer - EORTC2009-10-01
Post-operative or Early Salvage XRT and ADT for High Risk PCa (NCT00949962)European Organisation for Research and Treatment of Cancer - EORTC2009-10-01
Minimal SN Tumor Burden (NCT01942603)European Organisation for Research and Treatment of Cancer - EORTC2009-07-01
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate (NCT00956072)European Organisation for Research and Treatment of Cancer - EORTC2009-05-01
Sunitinib Malate in Treating Patients With Small Cell Lung Cancer (NCT00953459)European Organisation for Research and Treatment of Cancer - EORTC2009-02-01
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia (NCT00838240)European Organisation for Research and Treatment of Cancer - EORTC2008-11-01
Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer (NCT00766155)European Organisation for Research and Treatment of Cancer - EORTC2008-08-01
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery (NCT00646659)European Organisation for Research and Treatment of Cancer - EORTC2008-02-01
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) (NCT00626990)European Organisation for Research and Treatment of Cancer - EORTC2007-12-01
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma (NCT00626730)European Organisation for Research and Treatment of Cancer - EORTC2007-12-01
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer (NCT00623064)European Organisation for Research and Treatment of Cancer - EORTC2007-11-01
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors (NCT00526149)European Organisation for Research and Treatment of Cancer - EORTC2007-07-01
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas (NCT00516607)European Organisation for Research and Treatment of Cancer - EORTC2007-07-01
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx (NCT00498953)European Organisation for Research and Treatment of Cancer - EORTC2007-05-01
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma (NCT00458913)European Organisation for Research and Treatment of Cancer - EORTC2007-02-01
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer (NCT00450892)European Organisation for Research and Treatment of Cancer - EORTC2007-02-01
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes (NCT00433589)European Organisation for Research and Treatment of Cancer - EORTC2007-02-01
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer (NCT00438737)European Organisation for Research and Treatment of Cancer - EORTC2007-01-01
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma (NCT00424060)European Organisation for Research and Treatment of Cancer - EORTC2006-12-01
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602)European Organisation for Research and Treatment of Cancer - EORTC2006-11-01
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer (NCT00424164)European Organisation for Research and Treatment of Cancer - EORTC2006-11-01
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma (NCT00410462)European Organisation for Research and Treatment of Cancer - EORTC2006-10-01
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma (NCT00433433)European Organisation for Research and Treatment of Cancer - EORTC2006-10-01
Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery (NCT00389688)European Organisation for Research and Treatment of Cancer - EORTC2006-08-01
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer (NCT00263822)European Organisation for Research and Treatment of Cancer - EORTC2005-09-01
Radiation Therapy or Temozolomide in Treating Patients With Gliomas (NCT00182819)European Organisation for Research and Treatment of Cancer - EORTC2005-07-01
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma (NCT00227630)European Organisation for Research and Treatment of Cancer - EORTC2005-07-01
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00128700)European Organisation for Research and Treatment of Cancer - EORTC2005-06-01
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant (NCT00445952)European Organisation for Research and Treatment of Cancer - EORTC2005-02-01
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant (NCT00110045)European Organisation for Research and Treatment of Cancer - EORTC2005-02-01
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma (NCT00110123)European Organisation for Research and Treatment of Cancer - EORTC2005-01-01
Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer (NCT00103051)European Organisation for Research and Treatment of Cancer - EORTC2004-12-01
Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery (NCT00104936)European Organisation for Research and Treatment of Cancer - EORTC2004-12-01
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor (NCT00103168)European Organisation for Research and Treatment of Cancer - EORTC2004-12-01
NGR-TNF in Treating Patients With Advanced Solid Tumors (NCT00098943)European Organisation for Research and Treatment of Cancer - EORTC2004-09-01
Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00098982)European Organisation for Research and Treatment of Cancer - EORTC2004-09-01
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00091234)European Organisation for Research and Treatment of Cancer - EORTC2004-06-01
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery (NCT00086866)European Organisation for Research and Treatment of Cancer - EORTC2004-05-01
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00086879)European Organisation for Research and Treatment of Cancer - EORTC2004-05-01
Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00091156)European Organisation for Research and Treatment of Cancer - EORTC2004-05-01
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma (NCT00085475)European Organisation for Research and Treatment of Cancer - EORTC2004-04-01
Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma (NCT00085059)European Organisation for Research and Treatment of Cancer - EORTC2004-04-01
Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate (NCT00085228)European Organisation for Research and Treatment of Cancer - EORTC2004-04-01
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas (NCT00083096)European Organisation for Research and Treatment of Cancer - EORTC2004-03-01
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon (NCT00085163)European Organisation for Research and Treatment of Cancer - EORTC2004-03-01
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer (NCT00081237)European Organisation for Research and Treatment of Cancer - EORTC2004-02-01
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00079261)European Organisation for Research and Treatment of Cancer - EORTC2004-01-01
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome (NCT00077116)European Organisation for Research and Treatment of Cancer - EORTC2003-11-01
Infliximab in Treating Patients With Myelodysplastic Syndrome (NCT00074074)European Organisation for Research and Treatment of Cancer - EORTC2003-10-01
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides (NCT00074087)European Organisation for Research and Treatment of Cancer - EORTC2003-10-01
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer (NCT00068757)European Organisation for Research and Treatment of Cancer - EORTC2003-08-01
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer (NCT00068744)European Organisation for Research and Treatment of Cancer - EORTC2003-07-01
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer (NCT00066391)European Organisation for Research and Treatment of Cancer - EORTC2003-06-01
Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy (NCT00066339)European Organisation for Research and Treatment of Cancer - EORTC2003-05-01
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer (NCT00062400)European Organisation for Research and Treatment of Cancer - EORTC2003-05-01
Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer (NCT00066378)European Organisation for Research and Treatment of Cancer - EORTC2003-05-01
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer (NCT00064207)European Organisation for Research and Treatment of Cancer - EORTC2003-05-01
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer (NCT00064181)European Organisation for Research and Treatment of Cancer - EORTC2003-05-01
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00061984)European Organisation for Research and Treatment of Cancer - EORTC2003-04-01
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer (NCT00062335)European Organisation for Research and Treatment of Cancer - EORTC2003-04-01
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases (NCT00062348)European Organisation for Research and Treatment of Cancer - EORTC2003-04-01
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00060385)European Organisation for Research and Treatment of Cancer - EORTC2003-03-01
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides (NCT00056056)European Organisation for Research and Treatment of Cancer - EORTC2003-01-01
Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma (NCT00052754)European Organisation for Research and Treatment of Cancer - EORTC2002-10-01
Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer (NCT00049660)European Organisation for Research and Treatment of Cancer - EORTC2002-09-01
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer (NCT00052312)European Organisation for Research and Treatment of Cancer - EORTC2002-09-01
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00052299)European Organisation for Research and Treatment of Cancer - EORTC2002-09-01
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma (NCT00049595)European Organisation for Research and Treatment of Cancer - EORTC2002-08-01
Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor (NCT00047125)European Organisation for Research and Treatment of Cancer - EORTC2002-07-01
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery (NCT00004015)European Organisation for Research and Treatment of Cancer - EORTC2002-06-01
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00041236)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer (NCT00042887)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome (NCT00043134)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00041249)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care (NCT00045019)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer (NCT00043004)European Organisation for Research and Treatment of Cancer - EORTC2002-05-01
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231)European Organisation for Research and Treatment of Cancer - EORTC2002-04-01
Imatinib Mesylate in Treating Patients With Gliomas (NCT00039364)European Organisation for Research and Treatment of Cancer - EORTC2002-03-01
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer (NCT00039338)European Organisation for Research and Treatment of Cancer - EORTC2002-03-01
Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00039351)European Organisation for Research and Treatment of Cancer - EORTC2002-03-01
Assessing Quality of Life of Patients With Prostate Cancer (NCT00041301)European Organisation for Research and Treatment of Cancer - EORTC2002-03-01
Combination Chemotherapy in Treating Patients With Colorectal Cancer (NCT00039208)European Organisation for Research and Treatment of Cancer - EORTC2002-02-01
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00036868)European Organisation for Research and Treatment of Cancer - EORTC2002-02-01
Vaccine Therapy in Treating Patients With Melanoma of the Eye (NCT00036816)European Organisation for Research and Treatment of Cancer - EORTC2002-02-01
← Previous Next →

Track European Organisation for Research and Treatment of Cancer - EORTC automatically

Every clearance here is in the API, with alerts when new ones post.